Suchergebnisse - "Geurts, Sandra"

PubPharm (65)

11

Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer : an observational study of the SONABRE Registry

enthalten in: The Lancet regional health. Europe | 2023

von Meegdes, M. | Geurts, S. | Erdkamp, F. | +12

12

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry

enthalten in: Breast cancer research and treatment | 2023

von Ibragimova, K. | Geurts, S. | Meegdes, M. | +12

13

Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer : follow-up analysis of the randomised phase 3 DATA trial

enthalten in: EClinicalMedicine | 2023

von Tjan-Heijnen, V. | Lammers, S. | Geurts, S. | +12

14

Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study

enthalten in: European radiology | 2022

von Keymeulen, K. | Geurts, S. | Kooreman, L. | +7

15

Treatment and overall survival of four types of non-metastatic periampullary cancer : nationwide population-based cohort study

enthalten in: HPB : the official journal of the International Hepato Pancreato Biliary Association | 2022

von de Jong, E. | van der Geest, L. | Besselink, M. | +17

16

Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms : A population-based study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Poleé, I. | Hermans, B. | van der Zwan, J. | +13

17

Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma

enthalten in: International journal of cancer | 2022

von de Jong, E. | Janssen, Q. | Simons, T. | +14

18

Adjuvant and first-line palliative chemotherapy regimens in patients diagnosed with periampullary cancer : a short report from a nationwide registry

enthalten in: Acta oncologica (Stockholm, Sweden) | 2022

von de Jong, E. | Mommers, I. | Fariña Sarasqueta, A. | +10

19

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer : a study of the SONABRE registry

enthalten in: Breast cancer research and treatment | 2022

von Meegdes, M. | Ibragimova, K. | Lobbezoo, D. | +16

20

Quantifying the duration of the preclinical detectable phase in cancer screening : a systematic review

enthalten in: Epidemiology and health | 2022

von Geurts, S. | Aarts, A. | Verbeek, A. | +3